| 注册
首页|期刊导航|中国免疫学杂志|聚乙二醇衍生物修饰的IL-12制备及体外评价

聚乙二醇衍生物修饰的IL-12制备及体外评价

刘艺 邹镇阳 李宗艳 韩峰 乔天奎 王建刚

中国免疫学杂志2024,Vol.40Issue(7):1495-1500,1506,7.
中国免疫学杂志2024,Vol.40Issue(7):1495-1500,1506,7.DOI:10.3969/j.issn.1000-484X.2024.07.025

聚乙二醇衍生物修饰的IL-12制备及体外评价

Preparation and in vitro evaluation of polyethylene glycol derivatives modified IL-12

刘艺 1邹镇阳 1李宗艳 1韩峰 2乔天奎 3王建刚3

作者信息

  • 1. 中国海洋大学医药学院,青岛 266000||康立泰生物医药(青岛)有限公司,青岛 266000
  • 2. 中国海洋大学医药学院,青岛 266000
  • 3. 康立泰生物医药(青岛)有限公司,青岛 266000
  • 折叠

摘要

Abstract

Objective:To prepare IL-12 modified with polyethylene glycol derivatives and determine its modification sites,and to evaluate it in vitro in terms of stability,hemogram recovery,anti-tumor effects and other aspects.Methods:IL-12 was modified with polyethylene glycol propionaldehyde and maleimide imide derivatives,and modified sites of two different derivatives were deter-mined by ultra performance liquid chromatography(UPLC).Recombinant human IL-12 and PEG-IL-12 were used to stimulate NK92 cells,activity and cytotoxicity of IFN-γ were evaluated by kits.CD34+was stimulated to evaluate its blood picture recovery potential.NK cell killing was stimulated to evaluate its effectiveness in improving immunity and anti-tumor effects.Results:Compared with recombinant human IL-12,PEG-IL-12 had higher stability,blood picture recovery potential and anti-tumor effects.Conclusion:PEG-IL-12 can effectively overcome many drawbacks of recombinant human IL-12,greatly improving possibility of its widespread applica-tion in clinical trials.

关键词

聚乙二醇/IL-12/血象恢复/抗肿瘤

Key words

PEG/IL-12/Hemogram recovery/Anti-tumor

分类

医药卫生

引用本文复制引用

刘艺,邹镇阳,李宗艳,韩峰,乔天奎,王建刚..聚乙二醇衍生物修饰的IL-12制备及体外评价[J].中国免疫学杂志,2024,40(7):1495-1500,1506,7.

基金项目

国家科技重大专项"重大新药创制"(2017ZX09303017) (2017ZX09303017)

山东省重大科技创新工程项目(NO2018CXGC1404). (NO2018CXGC1404)

中国免疫学杂志

OA北大核心CSTPCD

1000-484X

访问量0
|
下载量0
段落导航相关论文